January 13, 2017 – Executive search firm Carmichael Fisher has been selected by the Coalition for Epidemic Preparedness Innovations (CEPI) to lead its search for a new chief executive officer. Principle consultant Tarquin Bennett-Coles is leading the assignment along with managing director Justin Hobday.
As a start-up global initiative leader, the incoming CEO of CEPI will need to demonstrate the ability to achieve results in situations of uncertainty, while working with the organization’s board and maintaining engagement with a diverse group of stakeholders. Experience in establishing a clear vision and communicating this across those stakeholders to ensure buy-in and the necessary engagement to deliver on the vision is ideal for this position.
The CEO also will need to demonstrate an ability to build a wide network of working relationships across global health organizations, global life sciences and the vaccine development ecosystem, as well as engage new partners and achieve buy-in across global stakeholders.
“The CEPI role has importance for global public health so finding the right individual for the coalition is vital. This person will need to create a compelling vision for CEPI while leading, managing and partnering with diverse stakeholder groups,” said Mr. Bennett-Coles. “They will need to engage with, and galvanise, the wider life science community, manage complex financial and fundraising affairs and support the board to create a sustainable operation.”
The Coalition for Epidemic Preparedness Innovations has a clear mandate: to stop future epidemics by faster developing new vaccines for a safer world. This means creating vaccines for diseases of epidemic potential ahead of an outbreak to reduce loss of life and lessen the social and economic impact of infectious disease outbreaks.
|Check out our latest upload from Carmichael Fisher|
Established in 2002, Carmichael Fisher is an international executive search firm with over 100 consultants, researchers and support staff. The firm focuses on senior level recruitment with a particular focus on financial services, legal & professional services, life sciences, manufacturing, transport & infrastructure, energy, real estate, media, and the retail & consumer sectors. The firm’s offices are in London, Brussels, Stockholm, Hamburg, Frankfurt, Lagos, Dubai, Singapore, Sydney and Melbourne.
Mr. Bennett-Coles has more than 18 years of life science executive search and interim management experience and has recently been working in partnership with biotech, digital health and rare and orphan disease SMEs as they commercialize across Europe and North America. He handles senior general management, C-suite and board level roles within the commercial, medical, clinical, HR and country management functions of biotech, medtech, informatics, pharmaceutical, diagnostics and allied technology businesses. In addition, he has partnered with, and supported, relevant industry associations, the VC community and the not-for-profit sector.
Mr. Hobday joined Carmichael Fisher in 2008 as managing director to develop the firm’s EMEA region. Since then, he has overseen the expansion from one office in London to now six locations across Europe and Africa, with growth every year. His experience is international and covers multiple sectors. He personally leads some of the firm’s most senior mandates and also leads its focus on non-executive appointments.
Contributed by Dale M. Zupsansky, Managing Editor, Hunt Scanlon Media